by myhealthteam | Feb 28, 2024 | Uncategorized
By Eric Peacock, Co-founder and CEO, MyHealthTeam Twelve years ago, rare diseases were overlooked by pharma, leaving rare disease research underfunded and patients underserved. However, a transformative shift occurred in 2012 when the FDA introduced the Breakthrough...
4 Pharma Marketing Moves to Make in 2024; Turnkey tactics to make before third-party cookies go away
by myhealthteam | Dec 7, 2023 | Uncategorized
As the industry faces the depreciation of third-party cookies, pharma marketers and ad agencies are looking for new ways to effectively target diagnosed patients. Here are four tactics that can be launched in-market within a matter of weeks that allow brands to engage...
Flipping the Script: Hope in the Face of Breast Cancer
by myhealthteam | Oct 12, 2023 | Uncategorized
Written by Mary Ray, Co-founder and COO, MyHealthTeam It was three and a half years ago when I felt swept up by a wave of biopsies, surgeries, and a myriad of medical appointments after being diagnosed with breast cancer. Juxtaposed against the daunting backdrop of a...
Zero Party Data Defined in 30 Seconds and Why It Matters to Health Marketers
by myhealthteam | Jul 12, 2023 | Uncategorized
By Eric Peacock, CEO and Co-founder, MyHealthTeam What Is Zero Party Data? You may have heard the phrase “zero party data,” but you’re still wondering what it means. Zero party data is information a customer intentionally and proactively shares with a company,...
Two Patient Research Studies Reveal Lower Access and Quality Care for Latino and Black Patients; MyHealthTeam and PHM Teaming Up To Improve Care for Underserved Populations
by myhealthteam | Jun 20, 2023 | Uncategorized
The impact of multiple sclerosis (MS) on the quality of life, mental health, and financial stability of patients is significant regardless of race. However, access to and quality care for MS is significantly lower for Latino and Black MS patients than it is for white...